Current NDC auxiliary source row compounder:70

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73013-1029
Product Ndc: 73013-1029
Product Ndc Digits: 730131029
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Fentanyl Citrate- Bupivacaine HCl
Proprietary Name Suffix: [empty]
Nonproprietary Name: fentanyl citrate, bupivacaine hydrochloride
Dosage Form Name: INJECTION, SOLUTION
Route Name: EPIDURAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: OurPharma LLC
Establishment Name: OurPharma LLC
Establishment Fei: [empty]
Substance Name: BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE
Active Ingredients Info: 1 mg/1 mL; 2 ug/1 mL
History Active Ingredients Raw: BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE
History Active Ingredients Info Raw: 1 mg/1 mL; 2 ug/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: CII
Package Ndc Raw: 73013-1029-1
Package Ndc: 73013-1029-1
Package Ndc Digits: 7301310291
Package Ndc11: 73013102901
Package Description: 100 mL in 1 BAG (73013-1029-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:70
Source Row Number: 70
Source Row Hash: 7c809f11bba0ecd6f92820dbe131030bc1baa7244fa8b731559518bd4773bf0b
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "EPIDURAL",
    "PRODUCTNDC": "73013-1029",
    "DEASCHEDULE": "CII",
    "LABELERNAME": "OurPharma LLC",
    "SUBSTANCENAME": "BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73013-1029-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Fentanyl Citrate- Bupivacaine HCl",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "fentanyl citrate, bupivacaine hydrochloride",
    "PACKAGEDESCRIPTION": "100 mL in 1 BAG (73013-1029-1) ",
    "ACTIVEINGREDIENTSINFO": "1 mg/1 mL; 2 ug/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:70
Source Row Number: 70
Status Scope: package
Lookup Ndc: 73013-1029-1
Lookup Ndc Digits: 7301310291
Product Ndc: 73013-1029
Product Ndc Digits: 730131029
Package Ndc: 73013-1029-1
Package Ndc Digits: 7301310291
Package Ndc11: 73013102901
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 7c809f11bba0ecd6f92820dbe131030bc1baa7244fa8b731559518bd4773bf0b
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20